Novel Insights into Diabetic Kidney Disease.

Recent findings on the efficacy of SGLT2 inhibitors in diabetic kidney disease are vital for improving patient outcomes in a prevalent risk group.

Source

Int J Mol Sci

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.